QNRX CIK: 1671502

Quoin Pharmaceuticals Ltd.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
8.20
FY22:
13.4
FY23:
11.3
FY24:
14.9
FY25:
20.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.16
FY22:
1.09
FY23:
0.88
FY24:
0.78
FY25:
0.38
Total assets
Change from FY21 to FY25
millions USD
FY21:
9.36
FY22:
14.5
FY23:
12.2
FY24:
15.7
FY25:
20.4

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.58
FY22:
3.53
FY23:
3.58
FY24:
4.18
FY25:
5.55
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.12
FY22:
3.52
FY23:
2.92
FY24:
2.32
FY25:
1.72
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.66
FY22:
7.41
FY23:
5.66
FY24:
9.20
FY25:
13.1
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
9.36
FY22:
14.5
FY23:
12.2
FY24:
15.7
FY25:
20.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data